Collectively, our findings highlight TMSB10 as a promising therapeutic target and prognostic biomarker in glioma, opening avenues for further research into the underlying mechanisms and potential clinical applications of targeting TMSB10 in this devastating disease. The gene discussed is TMSB10; the disease is glioma.